Nuzenio

Tradingview Apyx

Tradingview Apyx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Apyx Medical Corporation Revenue Breakdown – NASDAQ:APYX - TradingViewTradingView · Sat, 08 Aug 2026 03:10:56 GMTApyx Medical Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 22:04:08 GMTAPYX: AYON-driven revenue growth and margin expansion support a positive outlook for 2026 - TradingViewTradingView · Thu, 06 Aug 2026 21:51:43 GMTApyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:22:06 GMTAPYX: Q2 2026 revenue grew 22.1% with improved margins, but net losses and litigation risks continue - TradingViewTradingView · Thu, 06 Aug 2026 21:04:00 GMTApyx Medical Q2 revenue beats estimates on surgical aesthetics growth - TradingViewTradingView · Thu, 06 Aug 2026 20:40:23 GMTApyx Medical Reports Q2 2026 Revenue of $13.9M, Surgical Aesthetics Up 28% - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTApyx Medical Corporation Revenue Breakdown – DUS:BOV - TradingViewTradingView · Wed, 05 Aug 2026 18:37:35 GMT

Timeline

Sat, 08 Aug 2026 03:10:56 GMTApyx Medical Corporation Revenue Breakdown – NASDAQ:APYX - TradingView
Thu, 06 Aug 2026 22:04:08 GMTApyx Medical Q2 Earnings Call Highlights - TradingView
Thu, 06 Aug 2026 21:51:43 GMTAPYX: AYON-driven revenue growth and margin expansion support a positive outlook for 2026 - TradingView
Thu, 06 Aug 2026 21:22:06 GMTApyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 21:04:00 GMTAPYX: Q2 2026 revenue grew 22.1% with improved margins, but net losses and litigation risks continue - TradingView
Thu, 06 Aug 2026 20:40:23 GMTApyx Medical Q2 revenue beats estimates on surgical aesthetics growth - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Apyx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.